The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 105.00
Bid: 102.00
Ask: 108.00
Change: 0.00 (0.00%)
Spread: 6.00 (5.882%)
Open: 105.00
High: 105.00
Low: 105.00
Prev. Close: 105.00
IGP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Settlement of Patent Dispute

25 Mar 2010 12:30

RNS Number : 1650J
Intercede Group PLC
25 March 2010
 



25 March 2010

Intercede Group plc

("Intercede")

Settlement of Patent Litigation Between ActivIdentity and Intercede

Legal Action Terminated in California and UK

Highlights:

·; Intercede announces settlement of patent infringement disputes in the U.S. and the UK

 

·; The parties have settled the U.S. and UK litigations on mutually acceptable terms

 

London, United Kingdom 25 March 2010 - Intercede today announce that they have settled on mutually acceptable terms a lawsuit filed by ActivIdentity in the Northern District of California on 1 October 2008, and a lawsuit filed by Intercede in the UK High Court on 22 December 2009. 

The settlement entered on 23 March 2010 resolves patent litigation brought by ActivIdentity accusing Intercede's MyID products and Intercede's counterclaims alleging invalidity, violations of US antitrust law, fraud and unfair competition. This settlement includes a patent license, and the details of the settlement are confidential.

Richard Parris, Intercede's Chairman and Chief Executive, said:

 "We are pleased to end all outstanding legal disputes between Intercede and ActivIdentity and look forward to progressing our business. This settlement ensures that Intercede's worldwide partners and customers can continue to benefit from our leading MyID Identity and Credential Management System with confidence."

Intercede will take a charge to the current financial year for all of the exceptional costs associated with the legal fees relating to this case. It is not anticipated that the patent license agreement will have a material impact on Intercede's current or future earnings.

About Intercede

Intercede is the producer of the MyID® Identity and Credential Management System (IDCMS). Intercede's MyID is the only IDCMS software product that enables organizations to easily and securely manage the identities of people and their associated identity credentials within a single, integrated, workflow driven platform. This includes enabling and managing: secure registration, biometric capture, application vetting and approval through to smart card personalisation, issuance and management.

Intercede's MyID is being used around the world by large corporations, governments and banks to manage millions of identities for employees, citizens and customers. Notable deployments in the US include 10 Federal Agencies, a program with Lockheed Martin and two major US financial institutions. In Europe and the Middle East, Intercede's MyID is being deployed in support of government identity, health and corporate employee ID security projects.

For more information visit http://www.intercede.com

 

ENQUIRIES

Intercede Group plc

Richard Parris, Chairman & Chief Executive

Andrew Walker, Finance Director

Tel. +44 (0)1455 558111

FinnCap

Clive Carver /Charles Cunningham - Corporate Finance

Joanna Weaving - Corporate Broking

Tel. +44 (0)20 7600 1658

Pelham Public Relations

Archie Berens

Tel. +44 (0)20 7337 1509

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGMGZFRKZGGZG
Date   Source Headline
25th Feb 20157:02 amRNSNew Partner for Intercede's MyTAM Service
17th Feb 201511:00 amRNSLaunch of MyTAM - a fully hosted cloud service
5th Feb 20159:00 amRNSTransaction in Own Shares
3rd Feb 20157:00 amRNSTransaction in Own Shares
26th Jan 201510:19 amRNSDirector Share Dealings & Resignation
21st Jan 20157:00 amRNSTrading Statement
15th Jan 20157:00 amRNSTransaction in Own Shares
23rd Dec 20144:10 pmRNSTransaction in Own Shares
22nd Dec 20147:00 amRNSTransaction in Own Shares
19th Dec 201412:35 pmRNSExercise of Options and Total Voting Rights
19th Dec 20147:00 amRNSTransaction in Own Shares
18th Dec 20147:00 amRNSTransaction in Own Shares
17th Dec 20147:00 amRNSTransaction in Own Shares
15th Dec 20147:00 amRNSTransaction in Own Shares
12th Dec 20147:00 amRNSTransaction in Own Shares
5th Dec 20147:00 amRNSTransaction in Own Shares
3rd Dec 20147:00 amRNSTransaction in Own Shares
1st Dec 20147:00 amRNSTransaction in Own Shares
10th Nov 20149:28 amRNSDirector and PDMR Share Option Awards
6th Nov 20147:00 amRNSShare Buyback Programme
6th Nov 20147:00 amRNSHalf Yearly Report
7th Oct 20147:00 amRNSTrading Update
29th Sep 20147:00 amRNSFirst Customer: Derived Credentials for Mobile
17th Sep 20144:25 pmRNSResult of AGM
1st Aug 20147:00 amRNSShare Incentive Plan
26th Jun 20149:37 amRNSDirector/PDMR Shareholding
25th Jun 20141:20 pmRNSDirector Share Dealings
10th Jun 20147:00 amRNSDirector Share Dealings
5th Jun 20147:00 amRNSFinal Results
6th May 201410:32 amRNSShare Incentive Plan
1st Apr 20147:00 amRNSDirectorate Change
27th Mar 20147:00 amRNSTransaction in Own Shares
25th Mar 201410:35 amRNSTransfer of Treasury Shares
20th Mar 20147:00 amRNSTransaction in Own Shares
13th Mar 20147:00 amRNSTransfer of Treasury Shares
13th Mar 20147:00 amRNSShare Incentive Plan
4th Mar 20149:09 amRNSTransaction in Own Shares
27th Feb 20147:00 amRNSTransaction in Own Shares
13th Feb 20147:00 amRNSTransaction in Own Shares
7th Feb 20147:00 amRNSPartnership with TELUS and Gemalto
5th Feb 20147:00 amRNSTransaction in Own Shares
28th Jan 201411:30 amRNSTransaction in Own Shares
13th Jan 20147:00 amRNSShare Buyback Programme
8th Jan 20147:00 amRNSTrading Update
10th Dec 20136:00 pmRNSDirector Share Dealings
10th Dec 20134:49 pmRNSDirector Share Dealings
21st Nov 20137:00 amRNSHalf Yearly Report
5th Nov 20137:00 amRNSNew Contract Win
1st Oct 20137:00 amRNSDirector Share Dealings
26th Sep 20137:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.